Rama Shiva Lease Finance Private Limited has disclosed the acquisition of 4.04% of the total share capital in Biogen Pharmachem Industries Limited. The transaction, which occurred on October 16, 2026, involved the acquisition of 4,25,83,333 shares. This move represents a significant change in the shareholding pattern of Biogen Pharmachem Industries Limited. The acquisition was conducted through the Open Market route.
Shareholding Change in Biogen Pharmachem
Rama Shiva Lease Finance Private Limited has officially reported a change in its shareholding in Biogen Pharmachem Industries Limited. The company announced the acquisition of 4,25,83,333 equity shares, representing 4.04% of the total share capital of Biogen Pharmachem Industries Limited. This disclosure is made in accordance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Transaction Details
The acquisition took place on October 16, 2026, and was executed through the Open Market. Prior to this transaction, Rama Shiva Lease Finance Private Limited held no shares in Biogen Pharmachem Industries Limited. Following the acquisition, the company’s holding stands at 4.04% of the total diluted share capital. The total equity share capital of Biogen Pharmachem Industries Limited before and after the acquisition remains unchanged at Rs. 1,05,30,36,833, divided into 105,303,683 equity shares of Rs. 1/- each.
Target Company Information
Biogen Pharmachem Industries Limited is listed on the BSE Limited, with the scrip code 531752 and scrip ID BIOGEN. The total diluted share/voting capital of the target company after the acquisition remains Rs. 1,05,30,36,833.
Source: BSE
